The Blog

Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market

April 15, 2024 • 0 Comment
Share

In this episode of DeviceTalks Weekly, Greg Roche, CEO of Distalmotion, explains why smaller profile surgical robotic systems like Dexter have a shot at competing with established soft tissue giants. Just over two weeks to DeviceTalks Boston register now to meet Roche and other surgical robotics executives!

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network.

#DeviceTalks#DeviceTalks Weekly#Innovation#Interviews#podcast#Surgical Robotics

You might also like
Abbott’s Mahmood Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care
April 30, 2024
Abbott’s Mahmood Kazemi discusses a decade of diabetes advancements and the impact of CGM on diabetes care
It’s Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders
April 26, 2024
It’s Here! Share Your Story at DeviceTalks Boston Next Week Where You Can Meet Great Medtech Leaders
How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences
April 23, 2024
How do I take an approved medical device to market? with YJ Oh, Edwards Lifesciences




Share

Why Distalmotion’s Roche sees Dexter’s small size as big advantage in the robotics surgical market